| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protease binding | 3.08e-04 | 181 | 15 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | E-box binding | 9.40e-04 | 61 | 15 | 2 | GO:0070888 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 5.66e-03 | 152 | 15 | 2 | GO:0016779 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.96e-03 | 156 | 15 | 2 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.54e-03 | 188 | 15 | 2 | GO:0005201 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.18e-02 | 1244 | 15 | 4 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.27e-02 | 1271 | 15 | 4 | GO:0000987 | |
| GeneOntologyBiologicalProcess | positive regulation of skeletal muscle fiber development | 1.77e-05 | 9 | 15 | 2 | GO:0048743 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle fiber development | 4.47e-05 | 14 | 15 | 2 | GO:0048742 | |
| GeneOntologyBiologicalProcess | muscle cell fate commitment | 7.50e-05 | 18 | 15 | 2 | GO:0042693 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 8.51e-05 | 121 | 15 | 3 | GO:0090263 | |
| GeneOntologyBiologicalProcess | positive regulation of skeletal muscle tissue development | 1.47e-04 | 25 | 15 | 2 | GO:0048643 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 1.88e-04 | 158 | 15 | 3 | GO:0030177 | |
| GeneOntologyBiologicalProcess | mitochondrial DNA metabolic process | 1.98e-04 | 29 | 15 | 2 | GO:0032042 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle tissue development | 1.98e-04 | 29 | 15 | 2 | GO:1901863 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle tissue development | 2.57e-04 | 33 | 15 | 2 | GO:0048641 | |
| GeneOntologyBiologicalProcess | mitochondrial genome maintenance | 4.18e-04 | 42 | 15 | 2 | GO:0000002 | |
| GeneOntologyBiologicalProcess | base-excision repair | 5.02e-04 | 46 | 15 | 2 | GO:0006284 | |
| GeneOntologyBiologicalProcess | skeletal muscle fiber development | 5.69e-04 | 49 | 15 | 2 | GO:0048741 | |
| GeneOntologyBiologicalProcess | myotube cell development | 6.91e-04 | 54 | 15 | 2 | GO:0014904 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 6.91e-04 | 54 | 15 | 2 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of myotube differentiation | 7.17e-04 | 55 | 15 | 2 | GO:0010830 | |
| GeneOntologyBiologicalProcess | regulation of muscle tissue development | 7.70e-04 | 57 | 15 | 2 | GO:1901861 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 8.53e-04 | 60 | 15 | 2 | GO:0045005 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 1.05e-03 | 285 | 15 | 3 | GO:0060828 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle cell differentiation | 1.09e-03 | 68 | 15 | 2 | GO:0051155 | |
| GeneOntologyBiologicalProcess | somitogenesis | 1.36e-03 | 76 | 15 | 2 | GO:0001756 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.79e-03 | 343 | 15 | 3 | GO:0061448 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 1.80e-03 | 344 | 15 | 3 | GO:0060070 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 1.99e-03 | 92 | 15 | 2 | GO:0045661 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 2.03e-03 | 93 | 15 | 2 | GO:0060415 | |
| GeneOntologyBiologicalProcess | somite development | 2.08e-03 | 94 | 15 | 2 | GO:0061053 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 2.16e-03 | 96 | 15 | 2 | GO:0035914 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 2.19e-03 | 368 | 15 | 3 | GO:0030111 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 2.41e-03 | 381 | 15 | 3 | GO:0048545 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 2.44e-03 | 102 | 15 | 2 | GO:0048644 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 2.63e-03 | 106 | 15 | 2 | GO:0051149 | |
| GeneOntologyBiologicalProcess | segmentation | 3.52e-03 | 123 | 15 | 2 | GO:0035282 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 3.52e-03 | 123 | 15 | 2 | GO:0051153 | |
| MousePheno | abnormal susceptibility to hearing loss | 3.01e-06 | 38 | 11 | 3 | MP:0006334 | |
| MousePheno | abnormal extraocular muscle morphology | 8.43e-06 | 6 | 11 | 2 | MP:0005247 | |
| MousePheno | skin hyperplasia | 1.57e-05 | 8 | 11 | 2 | MP:0001214 | |
| MousePheno | abnormal skin cell number | 1.57e-05 | 8 | 11 | 2 | MP:0001213 | |
| MousePheno | abnormal myotome morphology | 1.57e-05 | 8 | 11 | 2 | MP:0003939 | |
| MousePheno | abnormal myotome development | 6.71e-05 | 16 | 11 | 2 | MP:0000737 | |
| MousePheno | abnormal rib development | 9.56e-05 | 19 | 11 | 2 | MP:0002823 | |
| MousePheno | abnormal synovial joint morphology | 1.07e-04 | 124 | 11 | 3 | MP:0030804 | |
| MousePheno | increased susceptibility to age-related hearing loss | 1.41e-04 | 23 | 11 | 2 | MP:0004748 | |
| MousePheno | abnormal bone ossification | 1.77e-04 | 395 | 11 | 4 | MP:0008271 | |
| MousePheno | short ribs | 2.10e-04 | 28 | 11 | 2 | MP:0004672 | |
| MousePheno | rib bifurcation | 2.59e-04 | 31 | 11 | 2 | MP:0000153 | |
| MousePheno | abnormal skeleton development | 2.85e-04 | 447 | 11 | 4 | MP:0002113 | |
| MousePheno | abnormal sternum ossification | 3.69e-04 | 37 | 11 | 2 | MP:0008277 | |
| MousePheno | abnormal eye muscle morphology | 5.72e-04 | 46 | 11 | 2 | MP:0003686 | |
| MousePheno | abnormal myogenesis | 7.31e-04 | 52 | 11 | 2 | MP:0000729 | |
| MousePheno | abnormal rib morphology | 9.09e-04 | 257 | 11 | 3 | MP:0000150 | |
| MousePheno | abnormal osteoblast differentiation | 1.00e-03 | 61 | 11 | 2 | MP:0008395 | |
| MousePheno | abnormal sternocostal joint morphology | 1.00e-03 | 61 | 11 | 2 | MP:0008148 | |
| MousePheno | abnormal skeleton physiology | 1.06e-03 | 632 | 11 | 4 | MP:0001533 | |
| MousePheno | abnormal cell cycle checkpoint function | 1.17e-03 | 66 | 11 | 2 | MP:0004045 | |
| Domain | Basic | 3.61e-06 | 4 | 15 | 2 | IPR002546 | |
| Domain | BASIC | 3.61e-06 | 4 | 15 | 2 | SM00520 | |
| Domain | Basic | 3.61e-06 | 4 | 15 | 2 | PF01586 | |
| Domain | - | 3.37e-03 | 109 | 15 | 2 | 4.10.280.10 | |
| Domain | HLH | 3.49e-03 | 111 | 15 | 2 | PF00010 | |
| Domain | HLH | 3.81e-03 | 116 | 15 | 2 | SM00353 | |
| Domain | BHLH | 3.87e-03 | 117 | 15 | 2 | PS50888 | |
| Domain | bHLH_dom | 3.94e-03 | 118 | 15 | 2 | IPR011598 | |
| Pathway | WP_HYPOXIADEPENDENT_DIFFERENTIATION_OF_MYOBLASTS | 4.30e-05 | 13 | 11 | 2 | MM15894 | |
| Pathway | REACTOME_MYOGENESIS | 1.51e-04 | 24 | 11 | 2 | MM15174 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.07e-04 | 28 | 11 | 2 | M48253 | |
| Pathway | REACTOME_MYOGENESIS | 2.22e-04 | 29 | 11 | 2 | M853 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.26e-04 | 161 | 11 | 3 | M27871 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 6.38e-04 | 49 | 11 | 2 | M48250 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 6.64e-04 | 50 | 11 | 2 | MM15817 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 7.19e-04 | 52 | 11 | 2 | M39782 | |
| Pubmed | Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. | 1.74e-07 | 2 | 15 | 2 | 8620528 | |
| Pubmed | Herculin, a fourth member of the MyoD family of myogenic regulatory genes. | 1.74e-07 | 2 | 15 | 2 | 2300571 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 9405106 | ||
| Pubmed | Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner. | 1.74e-07 | 2 | 15 | 2 | 33482196 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 12204280 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 8375340 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 2311584 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 8978788 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 8626014 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 1423602 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 18198342 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 8196663 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 12105204 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 9681116 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 11311165 | ||
| Pubmed | Ocular Motor Nerve Development in the Presence and Absence of Extraocular Muscle. | 5.21e-07 | 3 | 15 | 2 | 28437527 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 8391976 | ||
| Pubmed | Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. | 1.04e-06 | 4 | 15 | 2 | 1911647 | |
| Pubmed | Somite subdomains, muscle cell origins, and the four muscle regulatory factor proteins. | 1.04e-06 | 4 | 15 | 2 | 7929574 | |
| Pubmed | The myoD gene family: nodal point during specification of the muscle cell lineage. | 1.04e-06 | 4 | 15 | 2 | 1846704 | |
| Pubmed | Early skeletal muscle development proceeds normally in parthenogenetic mouse embryos. | 1.04e-06 | 4 | 15 | 2 | 8293880 | |
| Pubmed | Neuronal control of myogenic regulatory factor accumulation in fetal muscle. | 1.04e-06 | 4 | 15 | 2 | 17295338 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 21212806 | ||
| Pubmed | Skeletal muscle precursors in mouse esophagus are determined during early fetal development. | 1.04e-06 | 4 | 15 | 2 | 10974667 | |
| Pubmed | Genetic approaches for changing the heart and dissecting complex syndromes. | 1.04e-06 | 4 | 15 | 2 | 18601931 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 10635459 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 17039375 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 16614355 | ||
| Pubmed | A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. | 1.04e-06 | 4 | 15 | 2 | 17961534 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 10898959 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 10733231 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 9268580 | ||
| Pubmed | Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. | 1.73e-06 | 5 | 15 | 2 | 15386014 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 25378300 | ||
| Pubmed | Myogenic regulatory factors transactivate the Tceal7 gene and modulate muscle differentiation. | 1.73e-06 | 5 | 15 | 2 | 20307260 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 9343420 | ||
| Pubmed | Embryonic founders of adult muscle stem cells are primed by the determination gene Mrf4. | 1.73e-06 | 5 | 15 | 2 | 23623977 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 8627340 | ||
| Pubmed | Expression of myotonic dystrophy protein kinase gene during in vivo and in vitro mouse myogenesis. | 1.73e-06 | 5 | 15 | 2 | 9359635 | |
| Pubmed | Kbtbd5 is regulated by MyoD and restricted to the myogenic lineage. | 2.60e-06 | 6 | 15 | 2 | 24361185 | |
| Pubmed | Lineage of origin in rhabdomyosarcoma informs pharmacological response. | 2.60e-06 | 6 | 15 | 2 | 25030697 | |
| Pubmed | Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. | 2.60e-06 | 6 | 15 | 2 | 22460713 | |
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 26100884 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 2045411 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 36388973 | ||
| Pubmed | A conditional mouse model of synovial sarcoma: insights into a myogenic origin. | 2.60e-06 | 6 | 15 | 2 | 17418413 | |
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 10929709 | ||
| Pubmed | Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism. | 3.64e-06 | 7 | 15 | 2 | 23666760 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 14517256 | ||
| Pubmed | Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. | 3.64e-06 | 7 | 15 | 2 | 7589813 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 25490270 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 21316601 | ||
| Pubmed | KDM4A regulates myogenesis by demethylating H3K9me3 of myogenic regulatory factors. | 3.64e-06 | 7 | 15 | 2 | 34011940 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 9418854 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 21962509 | ||
| Pubmed | Immature adipocyte-derived exosomes inhibit expression of muscle differentiation markers. | 3.64e-06 | 7 | 15 | 2 | 33527775 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 18367555 | ||
| Pubmed | Lineage restriction of the myogenic conversion factor myf-5 in the brain. | 3.64e-06 | 7 | 15 | 2 | 8575308 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 16951257 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 21425413 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 25087979 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 1374351 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 9808779 | ||
| Pubmed | Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. | 4.85e-06 | 8 | 15 | 2 | 9609818 | |
| Pubmed | Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. | 4.85e-06 | 8 | 15 | 2 | 9268575 | |
| Pubmed | Mouse Pop1 is required for muscle regeneration in adult skeletal muscle. | 4.85e-06 | 8 | 15 | 2 | 11839816 | |
| Pubmed | MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. | 4.85e-06 | 8 | 15 | 2 | 7720554 | |
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 11201041 | ||
| Pubmed | Development and patterning of rib primordia are dependent on associated musculature. | 4.85e-06 | 8 | 15 | 2 | 32768399 | |
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 10037786 | ||
| Pubmed | Expression of myogenic regulatory factors during the development of mouse tongue striated muscle. | 4.85e-06 | 8 | 15 | 2 | 10669094 | |
| Pubmed | Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis. | 4.85e-06 | 8 | 15 | 2 | 18331721 | |
| Pubmed | 6.24e-06 | 9 | 15 | 2 | 35618666 | ||
| Pubmed | 6.24e-06 | 9 | 15 | 2 | 31685980 | ||
| Pubmed | 6.24e-06 | 9 | 15 | 2 | 15282310 | ||
| Pubmed | Pax3/Pax7 mark a novel population of primitive myogenic cells during development. | 6.24e-06 | 9 | 15 | 2 | 15964993 | |
| Pubmed | Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo. | 6.24e-06 | 9 | 15 | 2 | 17098221 | |
| Pubmed | Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury. | 6.24e-06 | 9 | 15 | 2 | 27746183 | |
| Pubmed | 7.80e-06 | 10 | 15 | 2 | 21422169 | ||
| Pubmed | 7.80e-06 | 10 | 15 | 2 | 22859371 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 7.80e-06 | 10 | 15 | 2 | 8950513 | |
| Pubmed | 7.80e-06 | 10 | 15 | 2 | 20193675 | ||
| Pubmed | Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. | 9.53e-06 | 11 | 15 | 2 | 7720708 | |
| Pubmed | 9.53e-06 | 11 | 15 | 2 | 10757985 | ||
| Pubmed | 1.14e-05 | 12 | 15 | 2 | 15893969 | ||
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 1.14e-05 | 12 | 15 | 2 | 28600496 | |
| Pubmed | Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. | 1.35e-05 | 13 | 15 | 2 | 9242638 | |
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 1.35e-05 | 13 | 15 | 2 | 7797078 | |
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 1.35e-05 | 13 | 15 | 2 | 10694423 | |
| Pubmed | 1.35e-05 | 13 | 15 | 2 | 34557486 | ||
| Pubmed | 1.58e-05 | 14 | 15 | 2 | 29323161 | ||
| Pubmed | 1.58e-05 | 14 | 15 | 2 | 20412779 | ||
| Pubmed | 1.58e-05 | 14 | 15 | 2 | 9284043 | ||
| Pubmed | 1.80e-05 | 383 | 15 | 4 | 19453261 | ||
| Pubmed | Fhl2 interacts with Foxk1 and corepresses Foxo4 activity in myogenic progenitors. | 1.82e-05 | 15 | 15 | 2 | 20013826 | |
| Pubmed | 1.82e-05 | 15 | 15 | 2 | 17194759 | ||
| Pubmed | 2.08e-05 | 16 | 15 | 2 | 22438570 | ||
| Pubmed | 2.08e-05 | 16 | 15 | 2 | 36227576 | ||
| Pubmed | 2.35e-05 | 17 | 15 | 2 | 15788460 | ||
| Pubmed | Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1. | 2.65e-05 | 18 | 15 | 2 | 26688546 | |
| Cytoband | 12q21 | 7.76e-06 | 13 | 15 | 2 | 12q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q21 | 9.58e-04 | 141 | 15 | 2 | chr12q21 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.60e-03 | 110 | 10 | 2 | 420 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.03e-05 | 18 | 14 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.03e-05 | 18 | 14 | 2 | MM1241 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.07e-04 | 29 | 14 | 2 | MM17055 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 1.35e-04 | 193 | 14 | 3 | M39321 | |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 1.45e-04 | 198 | 14 | 3 | M7620 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 1.48e-04 | 199 | 14 | 3 | M7553 | |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN | 1.50e-04 | 200 | 14 | 3 | M9773 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 1.50e-04 | 200 | 14 | 3 | M6263 | |
| Coexpression | GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 1.50e-04 | 200 | 14 | 3 | M7132 | |
| Coexpression | HALLMARK_MYOGENESIS | 1.50e-04 | 200 | 14 | 3 | M5909 | |
| Coexpression | BENPORATH_EED_TARGETS | 1.57e-04 | 1059 | 14 | 5 | M7617 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 3.08e-04 | 650 | 14 | 4 | M8448 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 5.74e-04 | 67 | 14 | 2 | M1686 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 5.91e-04 | 68 | 14 | 2 | M1373 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 6.45e-04 | 71 | 14 | 2 | MM1210 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 6.63e-04 | 72 | 14 | 2 | MM1131 | |
| Coexpression | LIN_MELANOMA_COPY_NUMBER_UP | 6.63e-04 | 72 | 14 | 2 | M346 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.26e-07 | 244 | 15 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 5.81e-07 | 249 | 15 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.66e-07 | 276 | 15 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.41e-06 | 298 | 15 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.12e-06 | 371 | 15 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 1.57e-05 | 489 | 15 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_200 | 2.09e-05 | 10 | 15 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_k3_200 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_100 | 6.30e-05 | 17 | 15 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.23e-04 | 384 | 15 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2 | 1.39e-04 | 147 | 15 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.54e-04 | 878 | 15 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 2.86e-04 | 479 | 15 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 3.23e-04 | 38 | 15 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 3.97e-04 | 967 | 15 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 3.97e-04 | 967 | 15 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 3.97e-04 | 967 | 15 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 3.99e-04 | 968 | 15 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 4.07e-04 | 972 | 15 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 4.09e-04 | 973 | 15 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 4.09e-04 | 973 | 15 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 4.14e-04 | 976 | 15 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.18e-04 | 978 | 15 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 4.30e-04 | 984 | 15 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_200 | 4.33e-04 | 44 | 15 | 2 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_500 | 5.60e-04 | 50 | 15 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.94e-04 | 241 | 15 | 3 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.35e-04 | 591 | 15 | 4 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.82e-04 | 265 | 15 | 3 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 9.33e-04 | 655 | 15 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.02e-03 | 290 | 15 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_500 | 1.29e-03 | 76 | 15 | 2 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_500 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_500 | 1.46e-03 | 81 | 15 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_k1_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_100 | 1.46e-03 | 81 | 15 | 2 | gudmap_kidney_adult_Mesangium_Meis_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.47e-03 | 330 | 15 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.49e-03 | 331 | 15 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.61e-03 | 85 | 15 | 2 | GSM777067_100 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_100 | 1.65e-03 | 86 | 15 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.65e-03 | 86 | 15 | 2 | GSM777055_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.68e-03 | 87 | 15 | 2 | GSM777050_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.80e-03 | 90 | 15 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_k1_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.09e-03 | 97 | 15 | 2 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.09e-03 | 97 | 15 | 2 | GSM777046_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_100 | 2.22e-03 | 100 | 15 | 2 | PCBC_ratio_EB_vs_SC_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 2.70e-03 | 408 | 15 | 3 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.87e-03 | 114 | 15 | 2 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.28e-03 | 437 | 15 | 3 | GSM777046_500 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 165 | 15 | 3 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-05 | 171 | 15 | 3 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-05 | 178 | 15 | 3 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue | 2.72e-05 | 179 | 15 | 3 | 535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 180 | 15 | 3 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.81e-05 | 181 | 15 | 3 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.00e-05 | 185 | 15 | 3 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 189 | 15 | 3 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 189 | 15 | 3 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 15 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 192 | 15 | 3 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.40e-05 | 193 | 15 | 3 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.40e-05 | 193 | 15 | 3 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.46e-05 | 194 | 15 | 3 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 194 | 15 | 3 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 194 | 15 | 3 | 889c6e231bdd5b59902c7d2afdc077360b1d3256 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.51e-05 | 195 | 15 | 3 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-05 | 195 | 15 | 3 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-05 | 195 | 15 | 3 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-05 | 195 | 15 | 3 | 773728703bc8969bff0e1de58fe3e1631add0a0a | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.56e-05 | 196 | 15 | 3 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-05 | 197 | 15 | 3 | 5bcf963f21d23edafef1e90dc1de24cd3b0fccce | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 3.62e-05 | 197 | 15 | 3 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-05 | 197 | 15 | 3 | bd7e18a0fed085cfb8ed0e478d1f172a173febbe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-05 | 197 | 15 | 3 | 7e06aee2add54eeff4a9927d9b04b5797160113b | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 3.73e-05 | 199 | 15 | 3 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 199 | 15 | 3 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-05 | 200 | 15 | 3 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-05 | 200 | 15 | 3 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-05 | 200 | 15 | 3 | c69173892d80b8592233928cb207a3f4b533b4b4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial-Proteoglycan-expressing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-05 | 200 | 15 | 3 | 94ef227b2162ba77af33b8cc8aaa4a7e3bdf79a7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-05 | 200 | 15 | 3 | 429028c3112d279b26abf3296e01b1884b4b7fcb | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-04 | 95 | 15 | 2 | ffbf3e362384c87b9db690ed39cd215e1f68375c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 126 | 15 | 2 | c3261ea8726400de87f1c8a5a5134ba2b2884f66 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-04 | 133 | 15 | 2 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tmem163_Dmrtb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.28e-04 | 136 | 15 | 2 | 0376c2907b869c7d42f57af7f65ffdd6246c4d27 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.42e-04 | 137 | 15 | 2 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.42e-04 | 137 | 15 | 2 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | facs-Skin-Anagen-24m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 138 | 15 | 2 | e8faf333553273b68a10b01470bb43a0383d6212 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.69e-04 | 139 | 15 | 2 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.01e-03 | 142 | 15 | 2 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-03 | 148 | 15 | 2 | e514b7cf412ddbee249894e089e2204c67bcdbce | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-03 | 152 | 15 | 2 | ee7855d76a49d07a032677a4dc83aa6116d50518 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-03 | 152 | 15 | 2 | 3a1414ba6a4972698c3262a00b124428835c35cb | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-03 | 153 | 15 | 2 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-03 | 155 | 15 | 2 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.22e-03 | 156 | 15 | 2 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-03 | 158 | 15 | 2 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 1.28e-03 | 160 | 15 | 2 | 9f7f24a52a24fb926df69c8e5aad64ee75a66ef1 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 1.28e-03 | 160 | 15 | 2 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-03 | 161 | 15 | 2 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-03 | 161 | 15 | 2 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-03 | 161 | 15 | 2 | aee74a2e7a8acd2950341963f1c04b59c7862183 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-03 | 161 | 15 | 2 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-03 | 161 | 15 | 2 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-03 | 161 | 15 | 2 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-03 | 161 | 15 | 2 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 162 | 15 | 2 | b24298910eb39ea5103ae24439b3901205ed55b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-03 | 162 | 15 | 2 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 164 | 15 | 2 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 164 | 15 | 2 | c721047f1b7abc0d0a3e14bdaabd1a7181231b94 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-03 | 164 | 15 | 2 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-03 | 165 | 15 | 2 | cca3ba9d7d30404e3e683b8cfd500c348a4974b9 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-03 | 165 | 15 | 2 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 166 | 15 | 2 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-03 | 166 | 15 | 2 | b041010038a570ad929812f35514cb54e4f68f66 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 166 | 15 | 2 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-03 | 167 | 15 | 2 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-03 | 168 | 15 | 2 | 2eed7dc1a2aff11be024823c4323c42bc94362f6 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-03 | 169 | 15 | 2 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-03 | 169 | 15 | 2 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-03 | 169 | 15 | 2 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-03 | 169 | 15 | 2 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.44e-03 | 170 | 15 | 2 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-03 | 170 | 15 | 2 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-03 | 170 | 15 | 2 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-03 | 170 | 15 | 2 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-03 | 171 | 15 | 2 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-03 | 171 | 15 | 2 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-03 | 171 | 15 | 2 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-03 | 171 | 15 | 2 | 59d79c3e36a4930af42ebc96f05570641b9fb864 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-03 | 171 | 15 | 2 | b6b90fcd9e9e379cad8bb0506f7ec7823861e313 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.46e-03 | 171 | 15 | 2 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 1.48e-03 | 172 | 15 | 2 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 1.48e-03 | 172 | 15 | 2 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-03 | 172 | 15 | 2 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-03 | 173 | 15 | 2 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | severe-B_memory|severe / disease stage, cell group and cell class | 1.49e-03 | 173 | 15 | 2 | 3a987ac53a0136cc4c70ce8b901a15fc00c795e1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 174 | 15 | 2 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-03 | 175 | 15 | 2 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-03 | 175 | 15 | 2 | 02c67a10cbe849fbf38f082f42517e42483e8cb7 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-03 | 175 | 15 | 2 | 79fd3e42c91846bda819e878a8eca8415d15ec55 | |
| Drug | Chloramphenicol | 6.70e-07 | 27 | 15 | 3 | ctd:D002701 | |
| Drug | AS31 | 2.43e-06 | 4 | 15 | 2 | CID016072241 | |
| Drug | AC1L1DW2 | 5.49e-06 | 186 | 15 | 4 | CID000002532 | |
| Drug | Tranexamic Acid | 1.82e-05 | 10 | 15 | 2 | ctd:D014148 | |
| Drug | 2-[amino-[(2R,3R)-4-(benzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 2.22e-05 | 11 | 15 | 2 | CID016122531 | |
| Drug | 2-[amino-[(2R,3R)-4-benzoxy-3-hydroxy-4-keto-2-mercapto-butanoyl]amino]acetic acid | 2.66e-05 | 12 | 15 | 2 | CID016122530 | |
| Drug | hydroxyethyl methacrylate | 3.15e-05 | 13 | 15 | 2 | ctd:C005044 | |
| Drug | cucurbitacin E | 6.88e-05 | 19 | 15 | 2 | ctd:C102326 | |
| Drug | pamidronate | 7.64e-05 | 20 | 15 | 2 | ctd:C019248 | |
| Drug | DEAB | 1.02e-04 | 23 | 15 | 2 | CID000056566 | |
| Drug | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 1.11e-04 | 24 | 15 | 2 | ctd:C518860 | |
| Drug | panobinostat | 1.26e-04 | 1333 | 15 | 6 | ctd:C496932 | |
| Drug | Coal Ash | 1.43e-04 | 159 | 15 | 3 | ctd:D060729 | |
| Drug | osthole | 1.52e-04 | 28 | 15 | 2 | CID000010228 | |
| Drug | NSC243743 | 2.25e-04 | 34 | 15 | 2 | CID000001064 | |
| Drug | de-E | 2.25e-04 | 34 | 15 | 2 | CID000215436 | |
| Drug | tricetin | 2.52e-04 | 36 | 15 | 2 | CID005281701 | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 3610_UP | |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 2877_UP | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 2240_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 2233_UP | |
| Drug | Asbestos, Amosite | 2.66e-04 | 37 | 15 | 2 | ctd:D017639 | |
| Drug | 2-[amino-[(2R,3R)-4-(dibenzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 2.66e-04 | 37 | 15 | 2 | CID016040231 | |
| Drug | NSC342435 | 2.66e-04 | 37 | 15 | 2 | CID000334935 | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5628_UP | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 6602_UP | |
| Drug | Dichlororibofuranosylbenzimidazole | 2.81e-04 | 38 | 15 | 2 | ctd:D004004 | |
| Drug | Daunorubicin | 3.52e-04 | 216 | 15 | 3 | ctd:D003630 | |
| Drug | dermatan sulfate | 3.72e-04 | 220 | 15 | 3 | CID000032756 | |
| Drug | 11-dehydrothromboxane B2 | 4.87e-04 | 50 | 15 | 2 | CID000001409 | |
| Drug | tetramethylpyrazine | 5.07e-04 | 51 | 15 | 2 | ctd:C017953 | |
| Drug | shikonin | 5.07e-04 | 51 | 15 | 2 | ctd:C016101 | |
| Drug | honokiol | 5.27e-04 | 52 | 15 | 2 | ctd:C005499 | |
| Drug | 3-methylquercetin | 5.48e-04 | 53 | 15 | 2 | ctd:C047368 | |
| Drug | sakyomicin A | 5.68e-04 | 54 | 15 | 2 | CID000124041 | |
| Drug | tetrandrine | 5.90e-04 | 55 | 15 | 2 | ctd:C009438 | |
| Drug | Fingolimod Hydrochloride | 5.90e-04 | 55 | 15 | 2 | ctd:D000068876 | |
| Drug | Tosylphenylalanyl Chloromethyl Ketone | 5.90e-04 | 55 | 15 | 2 | ctd:D014108 | |
| Drug | sunitinib | 6.33e-04 | 57 | 15 | 2 | ctd:C473478 | |
| Drug | 1,10-phenanthroline | 6.54e-04 | 267 | 15 | 3 | CID000001318 | |
| Drug | Phytochemicals | 6.56e-04 | 58 | 15 | 2 | ctd:D064209 | |
| Drug | 3-OH | 7.25e-04 | 61 | 15 | 2 | CID000068152 | |
| Drug | geranylgeranyl pyrophosphate | 7.49e-04 | 62 | 15 | 2 | ctd:C002963 | |
| Drug | Spermine | 7.73e-04 | 63 | 15 | 2 | ctd:D013096 | |
| Disease | Nephrotic Syndrome | 6.25e-05 | 27 | 13 | 2 | C0027726 | |
| Disease | Autosomal Dominant Parkinsonism | 6.73e-05 | 28 | 13 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 6.73e-05 | 28 | 13 | 2 | C0752097 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 6.73e-05 | 28 | 13 | 2 | C1868675 | |
| Disease | Parkinsonism, Experimental | 6.73e-05 | 28 | 13 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 6.73e-05 | 28 | 13 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 6.73e-05 | 28 | 13 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 6.73e-05 | 28 | 13 | 2 | C0242423 | |
| Disease | Parkinsonism, Juvenile | 7.74e-05 | 30 | 13 | 2 | C0752105 | |
| Disease | Parkinsonian Disorders | 7.74e-05 | 30 | 13 | 2 | C0242422 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.12e-04 | 36 | 13 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.76e-04 | 45 | 13 | 2 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Parkinson's disease (is_implicated_in) | 5.01e-04 | 76 | 13 | 2 | DOID:14330 (is_implicated_in) | |
| Disease | Cardiomyopathies | 1.46e-03 | 130 | 13 | 2 | C0878544 | |
| Disease | Tinnitus | 1.46e-03 | 130 | 13 | 2 | HP_0000360 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSSACMVCRRKKKRC | 96 | Q9UBU2 | |
| CKKCSESIPKDSLRM | 21 | P09874 | |
| ACKACKRKSTTMDRR | 71 | P13349 | |
| CISKKPTCCTRKMEE | 61 | P78333 | |
| ACKTCKRKSAPTDRR | 81 | P23409 | |
| DRCLRKEVTMDCKTP | 1186 | P54098 | |
| RQKKRMDSRPRAGCC | 11 | O75110 | |
| CAPGMECVKSRKRRK | 81 | Q16270 | |
| MADKMVRTPKCSRCR | 1 | Q96MA1 | |
| PIRQSSKCRKMDCKD | 151 | Q9UPX6 | |
| EKCTMPLTGKRCVDR | 451 | Q9BYC2 | |
| SRKNPARTCRDLKMC | 1251 | P02452 | |
| RNKVCSKCKRVRMPV | 971 | A0A0J9YWL9 | |
| SRRKTPMCEKCRKDS | 406 | Q8TF39 | |
| KRLGKLRCMRESCSS | 246 | Q96ME7 |